PTC Therapeutics to Participate at Upcoming Investor Conferences
PTC Therapeutics (NASDAQ: PTCT) has announced its participation in three major healthcare investor conferences in September 2025. The company will present at the Cantor Global Healthcare Conference on September 3 at 8:35 a.m. ET, the Wells Fargo Healthcare Conference on September 4 at 11:00 a.m. ET, and the Morgan Stanley Global Healthcare Conference on September 8 at 9:15 a.m. ET.
All presentations will be available via webcast on PTC's investor relations website and will remain accessible for 30 days after each event.
PTC Therapeutics (NASDAQ: PTCT) ha annunciato la partecipazione a tre importanti conferenze per investitori nel settore sanitario a settembre 2025. L'azienda presenterà al Cantor Global Healthcare Conference il 3 settembre alle 8:35 ET, al Wells Fargo Healthcare Conference il 4 settembre alle 11:00 ET e al Morgan Stanley Global Healthcare Conference l'8 settembre alle 9:15 ET.
Tutte le presentazioni saranno trasmesse via webcast sul sito per gli investitori di PTC e resteranno disponibili per 30 giorni dopo ciascun evento.
PTC Therapeutics (NASDAQ: PTCT) ha anunciado su participación en tres importantes conferencias para inversores del sector salud en septiembre de 2025. La compañía presentará en el Cantor Global Healthcare Conference el 3 de septiembre a las 8:35 a.m. ET, en el Wells Fargo Healthcare Conference el 4 de septiembre a las 11:00 a.m. ET y en el Morgan Stanley Global Healthcare Conference el 8 de septiembre a las 9:15 a.m. ET.
Todas las presentaciones estarán disponibles por webcast en la web de relaciones con inversionistas de PTC y permanecerán accesibles durante 30 días después de cada evento.
PTC Therapeutics (NASDAQ: PTCT)는 2025년 9월에 열리는 주요 헬스케어 투자자 콘퍼런스 세 곳에 참가한다고 발표했습니다. 회사는 Cantor Global Healthcare Conference에 9월 3일 오전 8:35(ET)에, Wells Fargo Healthcare Conference에 9월 4일 오전 11:00(ET)에, 그리고 Morgan Stanley Global Healthcare Conference에 9월 8일 오전 9:15(ET)에 발표할 예정입니다.
모든 발표는 PTC 투자자 관계 웹사이트를 통해 웹캐스트로 제공되며 각 행사 후 30일 동안 시청 가능합니다.
PTC Therapeutics (NASDAQ: PTCT) a annoncé sa participation à trois grandes conférences pour investisseurs du secteur de la santé en septembre 2025. La société présentera au Cantor Global Healthcare Conference le 3 septembre à 8h35 (ET), au Wells Fargo Healthcare Conference le 4 septembre à 11h00 (ET) et au Morgan Stanley Global Healthcare Conference le 8 septembre à 9h15 (ET).
Toutes les présentations seront diffusées en webcast sur le site investisseurs de PTC et resteront accessibles pendant 30 jours après chaque événement.
PTC Therapeutics (NASDAQ: PTCT) hat seine Teilnahme an drei wichtigen Healthcare-Investorenkonferenzen im September 2025 angekündigt. Das Unternehmen wird auf der Cantor Global Healthcare Conference am 3. September um 8:35 Uhr ET, auf der Wells Fargo Healthcare Conference am 4. September um 11:00 Uhr ET und auf der Morgan Stanley Global Healthcare Conference am 8. September um 9:15 Uhr ET präsentieren.
Alle Präsentationen werden per Webcast auf der Investor-Relations-Website von PTC verfügbar sein und sind jeweils 30 Tage nach der Veranstaltung abrufbar.
- None.
- None.
Cantor Global Healthcare Conference 2025
Wednesday, Sept. 3 at 8:35 a.m. ET
Wells Fargo 2025 Healthcare Conference
Thursday, Sept. 4 at 11:00 a.m. ET
Morgan Stanley 23rd Annual Global Healthcare Conference
Monday, Sept. 8 at 9:15 a.m. ET
The presentations will be webcast live on the Events and Presentations page under the Investor section of PTC Therapeutics' website at https://ir.ptcbio.com/events-presentations and will be archived for 30 days following the presentation. It is recommended that users connect to PTC's website several minutes before the start of the webcast to ensure a timely connection.
ABOUT PTC THERAPEUTICS, INC.
PTC is a global biopharmaceutical company dedicated to the discovery, development and commercialization of clinically differentiated medicines for children and adults living with rare disorders. PTC is advancing a robust and diversified pipeline of transformative medicines as part of its mission to provide access to best-in-class treatments for patients with unmet medical needs. The company's strategy is to leverage its scientific expertise and global commercial infrastructure to optimize value for patients and other stakeholders. To learn more about PTC, please visit www.ptcbio.com and follow on Facebook, X, and LinkedIn.
For More Information:
Investors:
Ellen Cavaleri
+1 (615) 618-6228
ecavaleri@ptcbio.com
Media:
Jeanine Clemente
+1 (908) 912-9406
jclemente@ptcbio.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/ptc-therapeutics-to-participate-at-upcoming-investor-conferences-302535211.html
SOURCE PTC Therapeutics, Inc.
FAQ
When is PTC Therapeutics (PTCT) presenting at the Cantor Global Healthcare Conference 2025?
How can investors access PTC Therapeutics' conference presentations in September 2025?
What investor conferences is PTC Therapeutics (PTCT) attending in September 2025?
What time is PTC Therapeutics presenting at the Morgan Stanley Healthcare Conference 2025?
